What's new in Interventional Cardiology

Designed By & For you, PCRonline offers a wealth of constantly updated information on interventional cardiovascular medicine. Whether you’re looking for the latest articles, cases, course presentations or videos, check out these pages regularly, or better yet, sign up for our newsletter and remain in the know!

Filter By

80 results

CLEAR-IE: outcomes of percutaneous mechanical aspiration in right-sided infective endocarditis

06 Oct 2025

Can mechanical aspiration offer a safer, less invasive option for managing right-sided infective endocarditis? The CLEAR-IE registry provides valuable early insights.

Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag
CLEAR-IE: outcomes of percutaneous mechanical aspiration in right-sided infective endocarditis

World Heart Day 2025: the Heart Team beyond the Cathlab

29 Sep 2025

September 29th marks the 25th anniversary of the creation of World Heart Day by the World Heart Federation. This day is dedicated to focusing international attention on cardiovascular disease (CVD), which remains one of the leading causes of mortality worldwide [1,2]. Today, we highlight the women...

World Heart Day 2025 - the Heart Team beyond the Cathlab

Clinical trial design

24 Sep 2025

Randomized clinical trials (RCTs) are the cornerstone of modern evidence-based medicine. The primary objective of an RCT is to provide unbiased estimates of the comparative efficacy and safety of various treatments and/or interventions. Interventional cardiology has undoubtedly been at the forefront of clinical research, with a...

Authors :

Sergio Buccheri, Stefan James
The PCR Textbook on clinical trial design

Sealing the risk: a case of left atrial appendage closure

15 Sep 2025

A 76-year-old woman with permanent atrial fibrillation, a history of breast cancer, and a recent diagnosis of an intestinal stromal tumour presents with a high thromboembolic and bleeding risk, making long-term anticoagulation unsafe. Cardiac CT reveals a challenging left atrial appendage anatomy. How would you treat this...

Sergio Berti

Author

Sergio Berti
Giovanni Benedetti

Author

Giovanni Benedetti
Luigi Emilio Pastormerlo

Author

Luigi Emilio Pastormerlo
Augusto Eposito

Author

Augusto Eposito
Marta Casula

Author

Marta Casula
Sealing the risk: a case of left atrial appendage closure

What’s new in the 2025 guidance on valvular heart disease - ESC Congress 2025

In this interview, Alex Sticchi speaks with Fabien Praz and Michael Borger, co-chairs of the 2025 ESC/EACTS Valvular Guidelines Task Force. They discuss the major updates, including the central role of multimodality imaging, the lowered age threshold for TAVI, the distinction between atrial and ventricular secondary...

What’s new in the 2025 guidance on valvular heart disease - ESC Congress 2025

DAPT-SHOCK-AMI trial: Cangrelor in cardiogenic shock

03 Sep 2025

Kalaivani Mahadevan and Fizzah Choudry provide their take on DAPT-SHOCK-MI presented by Zuzana Motovska at ESC Congress 2025 in Madrid.

Fizzah Choudry

Author

Fizzah Choudry
Kalaivani Mahadevan

Author

Kalaivani Mahadevan
DAPT-SHOCK-AMI trial: Cangrelor in cardiogenic shock

Key updates in valvular heart disease management: insights from the 2025 ESC/EACTS Guidelines

03 Sep 2025

Alex Sticchi provides his take on the new ESC Valvular Guidelines presented at the ESC Congress 2025 in Madrid.

Alessandro Sticchi

Author

Alessandro Sticchi
Key updates in valvular heart disease management: insights from the 2025 ESC/EACTS Guidelines

Surgical left atrial appendage occlusion in VHD without AF: OPINION Trial

03 Sep 2025

Alex Sticchi provides his take on the results of the OPINION trial presented by Yang Wang at the ESC Congress 2025 in Madrid.

Alessandro Sticchi

Author

Alessandro Sticchi
OPINION Trial: 1-year outcomes

TOP-CABG: the timing of platelet inhibition after coronary artery bypass grafting trial

02 Sep 2025

Jonathan Curio provides his take on TOP-CABG, presented by Xin Yuan at ESC Congress 2025 in Madrid.

Jonathan Curio

Author

Jonathan Curio
TOP-CABG: the timing of platelet inhibition after coronary artery bypass grafting trial

TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome

03 Sep 2025

Aaysha Cader provides her take on TACSI presented by Anders Jeppsson at ESC Congress 2025 in Madrid.

Author

Aaysha Cader
TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome